SOCM
ODTX

SR One Capital Management’s Odyssey Therapeutics ODTX Stock Holding History

SR One Capital Management’s Portfolio ODTX Stock Details ODTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71M Buy
+3,794,883
New +$66.5M 6.83% 6

Other funds holding ODTX

LMC
Lightspeed Management Company Menlo Park, California $2.4B AUM 7.07% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

SR One Capital Management's ODTX Position: Q2 2026 in Review

SR One Capital Management opened a new position in Odyssey Therapeutics (ODTX) in Q2 2026: 3,794,883 shares worth $71M. The stake represents 6.83% of the portfolio and ranks #6 among its holdings.

50 funds tracked by Wall St. Rank hold ODTX as of Q2 2026.

  • SR One Capital Management held 3,794,883 shares of Odyssey Therapeutics worth $71M as of Q2 2026.
  • Odyssey Therapeutics was a new SR One Capital Management position in Q2 2026.
  • Odyssey Therapeutics made up 6.83% of SR One Capital Management's portfolio in Q2 2026, its #6 holding.
  • 50 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q2 2026.

Based on SR One Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.